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    About 15% of couples have infertility problems, half of which are related to male factors. Cytogenetic 
and genetic disorders account for about 10% of the male infertility problems. The aim of this study was to 
determine the frequency and types of both cytogenetic abnormalities and AZF microdeletions of Y 
chromosome in idiopathic azoospermic and oligospermic infertile men in west of Iran. In this case-control 
study, a total of 108 infertile men including 62 azoospermic and 46 oligospermic men were studied for the 
cytogenetic and AZF microdeletions. Moreover, 90 fertile men served as a control group. Detailed clinical 
and laboratory examination was done for all participants. Karyotyping was done on peripheral blood 
lymphocytes to detect the cytogenetic abnormalities; likewise, multiplex-PCR method was performed to 
identify the presence of microdeletion in AZFa, AZFb or AZFc regions. Chromosomal abnormalities were 
detected in 6.5% (7/108) of cases, including two oligospermic men with balanced autosomal 
rearrangements, one oligospermic and four azoospermic men with Klinefelter syndrome. Y chromosome 
microdeletions were detected in 4.6% (5/108) of infertile men (AZFc: 3.7%, AZFbc: 0.9%). No AZFa 
deletion was detected in any of the patients. No chromosomal abnormality and Y chromosome 
microdeletion was detected in control group. The prevalence of chromosomal abnormalities and Y 
chromosome microdeletions shows the importance of genetic factors in male infertility. The analysis of 
karyotype and Y microdeletions in infertile men provide a proper understanding about the causes of 
infertility, the choice of the appropriate assisted reproduction technique and reducing the risk of 
transmission of these genetic defects to the future generation.  
 




     Infertility is a global medical problem. 
According to World Health Organization (WHO) 
definition, infertility is a disease of reproductive 
system, defined by the failure to achieve a clinical 
pregnancy after 12 months or more of regular 
unprotected sexual intercourse [1,2]. 
Approximately 15 to 20 % of all couples are 
infertile. It is suggested that 30 to 40% of infertile 
couples suffer from male factor infertility, while 
30 to 40% suffer from female factor infertility 
and the rest are due to factors involving both 
partners or due to unexplained causes [3]. Male 
infertility is a multifactorial syndrome, including 




a wide range of disorders and despite great 
advances in the field of infertility, 30% of male 
infertilities are still defined as idiopathic [4,5]. 
Male infertility is often caused by impairment of 
spermatogenesis. Sperm abnormalities include 
azoospermia (not having any measurable sperm 
in semen), oligospermia (low concentration of 
sperm), asthenospermia (reduced sperm motility), 
teratospermia (reduced levels of normal shaped 
sperm) and aspermia (complete lack of 
ejaculation)
 
[6]. Several factors are involved in  
male fertility which can be broadly divided into 
non-genetic factors (include varicocele, 
ejaculatory duct obstruction, sperm agglutination, 
sexual dysfunction and hormonal imbalance), 
epigenetic and genetic factors
 
[7, 8]. According to 
the latest findings, genetic factors account for 10 
to 15% of male infertility and include 
chromosomal aberrations and single gene 
mutations. About 30% of the cases of male 
infertility associated with impaired 
spermatogenesis (azoospermia or oligospermia) 
have no known cause (a condition   defined as 
idiopathic male infertility); however, in 30 to 
40% of these cases, genetic abnormality is 
suspected
 
[9]. Chromosomal abnormalities are 
among the most important genetic causes of male 
infertility whose prevalence is estimated between 
2.1 to 28.4%; this prevalence increases as the 
number of sperms decreases. Chromosomal 
abnormalities may be numerical or structural and 
involve sex chromosomes or autosomes. 
Klinefelter syndrome, also known as 47, XXY or 
XXY, is the most important genetic cause of male 
infertility
 
[10]. The Y is one of the smallest 
human chromosomes spans (more than 58 million 
base pairs) and represents almost 2% of the total 
DNA in human genome. The main role of this 
chromosome is to create sperm; however, 
molecular mechanisms of spermatogenesis and its 
relationship with Y chromosome are not 
completely understood. After the Klinefelter 
syndrome, microdeletions of Y chromosome are 
the second most frequent genetic cause of 
infertility in men [11]. Polymerase chain reaction 
(PCR) studies of the sequence tagged site (STS) 
of Y chromosome in infertile men indicate the 
occurrence of microdeletions in a region of Y 
chromosome which are not detectable by 
karyotype analysis. These studies have led to the 
identification of three non-overlapping loci in 
Yq11, named as the azoospermia factor (AZF) 
which carry those genes involved in the control of 
spermatogenesis and are divided into AZFa, 
AZFb, and AZFc regions
 
[12]. Microdeletions 
within the AZFa and AZFb regions leads to 
sertoli cell only (SCO) syndrome and 
spermatogenic arrest, whereas deletions in AZFc 
can cause different phenotypes ranging from 
normal to oligozoospermia and azoospermia [13]. 
The genes located in AZF region code proteins 
are involved in the regulation of gene expression, 
RNA splicing and metabolism and packaging and 
transport to cytoplasm [14]. In recent years, using 
assisted reproductive technologies (ART) such as 
testicular sperm extraction (TESE) and 
intracytoplasmic sperm injection (ICSI) for 
treatment of male infertility has allowed the use 
of sperm from oligospermic or azoospermic 
males to obtain successful fertilization and 
pregnancies [15]. This procedure has raised some 
concerns about the potential transmission of 
genetic abnormalities to the next generation, since 
the natural selection process of sperm cells is 
bypassed [16]. So this study aims at determining 
the prevalence and types of chromosomal 
abnormalities and Y chromosome microdeletions 
in infertile men with idiopathic oligo and 
azoospermia in order to provide appropriate 
genetic counseling to patients referred for assisted 
reproductive treatment in west of Iran. 
 
MATERIALS AND METHODS 
Study design  
     This study was carried out on men referred to 
the Motazedi Infertility Teaching Clinic of 




Kermanshah University of Medical Sciences to 
employment of assisted reproduction techniques 
because of severe male factor infertility, between 
November 2014 and June 2016. After detailed 
clinical examination, patients were subjected to 
semen and endocrinological examinations. 
Diagnosis of azoospermia and oligospermia was 




investigations include measurement of serum 
Follicle Stimulating Hormone (FSH), Luteinizing 
Hormone (LH) and Testosterone levels were 
determined using ELISA method (Roche Elecsys, 
Germany). All subjects were of Iranian ethnic 
origin and gave relevant informed consent. This 
research was approved according to official 
Iranian law and regulations by the Institutional 
Review Boards of each participating teaching and 
referral hospital. The present study also complies 
with the Declaration of Helsinki. Patients having 
any cryptorchidism, congenital absence of vas 
deferens, seminal tract obstruction, varicocele, 
testicular tumors or undergoing chemotherapy 
and radiotherapy were excluded from this study 
and finally, 108 men with idiopathic non 
obstructive azoospermia and oligosperma were 
included. These patients were separated into two 
groups: group A: men with non-obstructive 
azoospermia (n= 62) and group B: men with 
severe oligospermia (n= 46). Ninety age-matched 
normozospermic fertile men who had at least one 
child were considered as control group (group C). 
Statistical analysis was carried out using SPSS for 
windows 16.0 software and P<0.05 was 
considered statistically significant. 
Chromosomal analysis  
     All patients and controls were analyzed 
cytogenetically. Karyotype analysis was 
performed on blood lymphocyte cultures using 
standard cytogenetic methods. Briefly, blood cells 
were cultured in RPMI 1640 medium containing 
20% fetal bovine serum (FBS) and 10 μg/ml 
phytohaemagglutin as the mitogen and  were 
incubated at 37°C for 68 to 72 hours. Afterwards,  
colcemid was added to the medium and incubated 
at 37°C for 10 minutes. The medium was 
centrifuged and the pellets were resuspended in 5 
to 10 ml KCl (0.075 M) for 20 minutes at 37°C. 
After centrifugation, the cells were resuspended 
in a fixative solution (methanol: acetic acid, 3:1). 
The fixative was replaced for a minimum of 3 
times. By using a Pasteur pipette, drops of the 
solution were poured on slides for morphological 
studies. The chromosomes were viewed under a 
phase-contrast microscope to assess metaphase 
quality and the nuclei. The chromosomes were 
stained by GTG banding technique and 
karyotyped after aging. A 400-band stage 
resolution was applied for analysis. A minimum 
of twenty metaphases were counted for each 
sample. The chromosomal abnormalities were 
described according to the guideline by the 




Analysis of the AZF genes by PCR-sequence-
tagged sites 
     1 ml of blood samples were taken from all the 
patients and controls and collected in tubes 
containing EDTA. Genomic DNA was isolated 
from peripheral blood leukocyte using QIAGEN 
DNA extraction kit and stored in –20°C. The 
PCR comprised a total volume of 25 μL, of which 
10 μL was the master mix (2X) (Amplicon, 
Denmark), 0.1–0.5μmol/L of each primer, 100 ng 
of genomic DNA, and 8 μL of enzyme-free water. 
A series of 6 STS markers on the long arm of Y 
chromosome were used for detection of   
microdeletions according to the European 
Academy of Andrology (EAA) and European 
Molecular Genetic Quality network (EMQN). 
The markers consisted of sY84 and Sy86 for 
AZFa, sY127 and sY134 for AZFb, sY254 and 
sY255 for AZFc regions. Also two primer pair 
that amplifies specific STS of SRY and ZFY gene 
was used as positive control. The sequence and 
size of all of primers are shown in table 1. DNA 
was amplified by multiplex PCR method. Two 
sets of amplification reactions were used. In each 
PCR, three STS primers and two internal controls 
were used. Amplification was carried out for 35 
cycles in a Eppendorf Mastercycleras as follows: 
denaturation at 94
o
C for 30 s, annealing at 57
o
C 
for 90 s and extension at 72
o
C for 60 s. 
Amplification cycles were proceeded by initial 




denaturation for 15 min at 95
o
C and final 
extension at 72
o
C for 5 min. In each PCR 
reactions, DNA from normal fertile males was 
used as normal control, while water served as 
negative control. The PCR products were 
separated on a 2% agarose gel prepared in 1× 
TBE buffer containing GelRed dye by 
electrophoresis [8]. A 100bp DNA marker 
(Fermentas) was loaded with PCR products to 
confirm the band size. A positive result was 
scored when the amplification product of 
expected size was obtained. Deletion of PCR 
fragments was confirmed by three repetitions. 
 
Table 1. Sequence-Tagged Sites (STS) and gene-specific primer sequences for deletion analysis 




ZFY-F 5-ACC RCT GTA CTG ACT GTG ATT ACA C-3 
495 
ZFY-R 5-GCA CYT CTT TGG TAT CYG AGA AAG T-3 
SRY 
sY14-F 5-GAA TAT TCC CGC TCT CCG GA-3 
472 
sY14-R 5-GCT GGT GCT CCA TTC TTG AG-3 
Reaction A    
AZFa 
sY86-F 5-GTG ACA CAC AGA CTA TGC TTC-3 
318 
sY86-R 5- ACA CAC AGA GGG ACA ACC CT -3 
AZFb 
sY127-F 5-GGC TCA CAA ACG AAA AGA AA-3 
274 
sY127-R 5-CTG CAG GCA GTA ATA AGG GA-3 
AZFc 
sY254-F 5-GGG TGT TAC CAG AAG GCA AA-3 
380 
sY254-R 5-GAA CCG TAT CTA CCA AAG CAG C-3 
Reaction B    
AZFa 
sY84-F 5-AGA AGG GTC CTG AAA GCA GGT-3 
326 
sY84-R 5-GCC TAC TAC CTG GAG GCT TC-3 
AZFb 
sY134-F 5-GTC TGC CTC ACC ATA AAA CG-3 
301 
sY134-R 5-ACC ACT GCC AAA ACT TTC AA-3 
AZFc 
sY255-F 5-GTT ACA GGA TTC GGC GTG AT-3 
123 




     This study was performed on 108 men who 
were candidate for ICSI which were separated 
into two groups: group A: men with non-
obstructive azoospermia (n = 62; 57.4 %), and 
group B: men with severe oligospermia (n= 46; 
42.6 %). The average duration of infertility was 
7.2 years (range 1–20 years). Characteristics of 
age and hormonal analysis results of infertile 
males and controls are mentioned in Table 2. 
 










Age (years) 32.4±6.4 31.5±7.2 34±5.9  
Testosterone 4.9±2.8 5.0±2.5 5.4±2.6 2.8-8 ng/ml 
LH 12.1±6.3 10.5±6.7 4.9±2.1 1.7-8.6 mIU/ml 
FSH 19.8±4.6 14.6±7.5 8.2±5.3 1.5-12.4 mIU/ml 
 
Cytogenetic analysis 
     Cytogenetic analysis showed that from 108 
infertile men, 100 males (92.6 %) had normal 
karyotype (46; XY), and 7 men (6.5 %) had 
various chromosomal abnormalities. Four 
chromosomal anomalies were detected in the 
azoospermic patients (4/62 = 6.4%) and three in 
the oligospermic patients (3/46 = 6.5%). The 
most frequent chromosomal anomaly was 
Klinefelter syndrome (5/108= 4.6%) (Figure 1). 




Four of Klinefelter syndrome KS cases were in 
the azoospermic group (4/62 = 6.4%) and one 
was in the oligospermic group (1/46 = 2.8%); 
moreover, in oligospermic group, one case of 
balanced Robertsonian translocation 45, XY,der 
(13q,14q) and one case of balanced reciprocal 




Figure 1. Karyotype of an azoospermic patient with klinefelter syndrome 
 
Microdeletions in the Yq11 region 
     The total frequency of microdeletions detected 
in infertile men was 4.6% (5/108). Y 
chromosome microdeletions were detected in 3 of 
62 (4.8%) azoospermic and 2 of 46 (4.3%) 
oligospermic men. Frequency and types of 
deleted region are shown in table 3. No AZFa 
microdeletion was detected in in infertile men. 
All the men with AZF microdeletions had normal 
karyotype (46,XY) and combination of 
chromosomal abnormality and Y chromosome 
microdeletion was not seen in any infertile men.  
 




karyotype Deleted AZF 
Azoospermia   AZFa AZFb AZFc 
 6 46,XY - - sY254 sY255 
 19 47,XYY - - - 
 22 46,XY - - sY254 sY255 
 30 47,XYY - - - 
 41 47,XYY - - - 
 46 47,XYY - - - 
 58 46,XY - sY134 sY254 sY255 
Oligospermia      
 9 46,XY - - sY254 
 15 45, XY,der (13q,14q) - - - 
 22 46,XY - - sY254 
 34 47,XYY - - - 
 43 46,XY,t(11;22)(q23.3;q11.2) - - - 
 
Total genetic abnormality rate 
     The results of  cytogenetic and Y chromosome 
microdeletions analysis showed that from 108 
infertile men included in the study, 12 3males 
(11.1 %) had chromosomal abnormality or Y 
chromosome microdeletion. Also total genetic  
abnormality rate (include chromosomal 
abnormality and Y chromosome microdeletions) 
was 11.2 % in azoospermic males (7/62) and 10.8 
% in oligospermic males (5/46). No men in 
control group show chromosomal abnormality or 
AZF micro deletion. 





     Male infertility has attracted a great deal of 
attention from many genetic and biology 
researchers and until now, many genetic 
aberrations have been identified, which are 
involved in spermatogenesis impairment and 
fertility
 
[1]. In the present study, the frequency of 
chromosomal abnormalities is more than the 
frequency of the Y chromosome microdeletions 
(6.5% vs 4.6%). These findings are in accordance 
with those reported in earlier studies [5,11,12].    
Sex chromosome abnormalities are the most 
common genetic cause of infertility. These 
abnormalities are associated with severe 
spermatogenesis impairment, leading to a 
significant reduction in testis volume and 
azoospermia or severe oligospermia [3,4]. In the 
present study,  five males were proved to have  
Klinefelter syndrome (47,XXY karyotype), four 
of which had azoospermia and one had severe 
oligospermia. A relationship between balanced 
autosomal translocation and infertility has been 
reported in azoospermic and severely 
oligospermic men. In the present study, the 
frequency of autosomal chromosome 
abnormalities was 1.8% (2/108). These 
abnormalities include one case of reciprocal 
translocation [t(11;22)] and one case of 
Robertsonian translocation [der (13q,14q)], 
detected in oligospermia group. It is believed that 
the balanced translocations may disrupt normal 
chromosome pairing and disjunction during 
meiosis I, which can lead to the production of 
gametes with unbalanced genetic makeup and 
subsequent apoptosis of gametes. Another 
possible mechanism, based on possible autosomal 
genes is involved in spermatogenesis which 
might be disrupted by chromosome breakpoints 
[4]. In this study, sex chromosome aberrations are 
more frequent than autosomal abnormalities. 
These results are similar to those reported in other 
studies
 
[17,18]; Amouri et al. (2014) reported that 
aberrations of sex chromosomes are more 
common in azoospermic men, while aberrations 
of autosomal chromosomes are more common in 
severe oligospermic ones [10]. AZF regions are 
located in the long arm of Y chromosome. It is 
believed that deletions in these regions can affect 
genes controlling spermatogenesis process. The 
frequency of AZF microdeletions are different 
from one study to another; it may be due to the 
different factors such as ethnicity of the study 
population, selection of inclusion criteria and 
variation in the number of STS markers used in 
various studies
 
[1].  In this study, we used six 
primer pairs according to EAA/EMQN guideline 
and reported 3.7% of microdeletions in AZFc 
region and 0.9% in AZFb,c regions. Previous 
studies have reported that the frequency of Yq 
microdeletions varied from 1% to 55% among 
infertile men, but the majority of studies have 
mentioned that this ratio is below 15%
 
[2, 13]. In 
our study, the frequency of microdeletion was 
4.8% and 4.3% among azoospermic and 
oligospermic men respectively, which is similar 
to the majority of previously published studies
 
[3, 
7]. None of the patients in the present study 
showed deletion in AZFa region using sY84 and 
sY86 STS. AZFa region includes single copies of 
DDX3Y and USP9Y genes. Detection of 
deletions in the AZFa region is very crucial 
because it is impossible to retrieve testicular 
sperm for TESE/ICSI procedure [4]. In the 
present study, one azoospermic male showed 
partial deletion in AZFb region in combination 
with AZFc deletion, whereas no infertile men 
showed complete deletion in AZFb region, either 
alone or in combination with other deletions. 
Deletions of AZFb region may cause SCO 
syndrome or spermatogenetic arrest in 
azoospermic males. RBM1 and RBM2 genes are 
located in AZFb region and are specifically 
expressed in testicular tissues and germ cells. 
These two genes encode RNA binding proteins 
that are localized to the nucleus of spermatogenic 
cells
 
[5]. Deletions in the AZFc region are the 
most commonly reported deletions among AZF 
regions. The most important candidate gene in 
AZFc region is the two clusters of DAZ gene 
family, BPY2 and CDY1 genes which control 
spermatogenesis. Deletions of AZFc region may 
have variable effects on male fertility potential  
according to the deleted genes [6].  
In our study, deletions detected in AZFc region 
using sY254 and sY255 STS, account for 4.6 % 
of total AZF deletions were found in patients. 
Partial or complete deletions in AZFc region may 
result in different phenotypes, varying from 
normal sperm count to oligospermia and 




azoospermia; thus, there is a chance for retrieving 
sperm from testis and performing TESE/ ICSI for 
these patients
 
[11]. Studies performed in different 
part of Iran have reported different results 
compared to our study. Omrani and colleagues 
(2009) reported that the frequency of Y 
chromosome microdeletions among azoospermic 
men of the Kurd and Azari ethnic origin in North 
West of Iran was about 30%
 
[2]. Mirfakhraie and 
colleagues (2010) showed that the frequency of Y 
chromosome microdeletion was 12% among 
azoospermic and oligozoospermic men from 
central of Iran; they also reported that the most 
frequent microdeletions were in the AZFb region 
followed by AZFc region [16]. Malekasgar and 
colleagues (2008) also indicated that the 
frequency of microdeletions in Y chromosome in 
azoospermic men from South West of Iran was 
51.6% which is higher than the international 
frequency
 
[9]. These variations in frequencies of 
deletion may be due to ethnic and geographic 
origins of the studied population or differences in 
the study design including the sample size and 
different STS selection.  
 
CONCLUSION 
     The analysis of karyotype and Y 
microdeletions among infertile men is highly 
recommended for the purpose of providing a 
proper understanding of the causes of infertility, 
choosing the appropriate assisted reproduction 
technique and reducing the risk of transmission of 
these genetic defects to the future generation. 
 
 “The authors declare no conflict of interest” 
 
REFERENCES 
1.Balkan M, Tekes S, Gedik A. Cytogenetic and 
Y chromosome microdeletion screening studies in 
infertile males with Oligozoospermia and 
Azoospermia in Southeast Turkey. Journal of 
assisted reproduction and genetics 2008; 25(11-
12):559-65. 
2.Omrani MD, Samadzadae S, Bagheri M, Attar 
K. Y chromosome microdeletions in idiopathic 
infertile men from West Azarbaijan. Urology 
journal 2009; 3(1):38-43. 
3.Naasse Y, Charoute H, El Houate B, Elbekkay 
C, Razoki L, Malki A, Barakat A, Rouba H. 
Chromosomal abnormalities and Y chromosome 
microdeletions in infertile men from Morocco. 
BMC urology 2015;15(1):1. 
4.Pina-Neto JM, Carrara RC, Bisinella R, 
Mazzucatto LF, Martins MD, Sartoratto E, 
Yamasaki R. Somatic cytogenetic and  
azoospermia factor gene microdeletion studies in 
infertile men. Brazilian journal of medical and 
biological research 2006; 39(4):555-61. 
5.Zaimy MA, Kalantar SM, Sheikhha MH, 
Jahaninejad T, Pashaiefar H, Ghasemzadeh J, 
Zahraei M. The frequency of Yq microdeletion in 
azoospermic and oligospermic Iranian infertile 
men. Iranian journal of reproductive medicine 
2013; 11(6):453. 
6.Sheikhha MH, Zaimy MA, Soleimanian S, 
Kalantar SM, Rasti A, Golzade M, Fahraji HH. 
Multiplex PCR Screening of Y-chromosome 
microdeletions in azoospermic ICSI candidate 
men. Iranian journal of reproductive medicine 
2013;11(4):335. 
7.Wiland E, Yatsenko AN, Kishore A, Stanczak 
H, Zdarta A, Ligaj M, Olszewska M, Wolski JK, 
Kurpisz M. FISH and array CGH characterization 
of de novo derivative Y chromosome (Yq 
duplication and partial Yp deletion) in an 
azoospermic male. Reproductive biomedicine 
online 2015; 31(2):217-24. 
8.Krausz C, Hoefsloot L, Simoni M, Tüttelmann 
F. EAA/EMQN best practice guidelines for  
molecular diagnosis of Y‐chromosomal 
microdeletions: state‐of‐the‐art 2013. Andrology. 
2014; 2(1):5-19. 
9.Malekasgar AM, Mombaini H. Screening 
of'Y'chromosome microdeletions in Iranian 
infertile males. Journal of human reproductive 
sciences 2008;1(1):2. 
10.Amouri A, Hammami W, Kilani O, Bouzouita 
A, Ayed W, Meftah MB, Khrouf M, Fadhlaoui A, 
Abdelhak S, Zhioua F, Jaafoura MH. 
Chromosomal evaluation in a group of Tunisian 
patients with non-obstructive azoospermia and 
severe oligozoospermia attending a Tunisian 




cytogenetic department. Comptes rendus 
biologies 2014; 337(4):223-8. 
11.Zhang YS, Li LL, Xue LT, Zhang H, Zhu YY, 
Liu RZ. Complete AZFb Deletion of Y 
Chromosome in an Infertile Male with Severe 
Oligoasthenozoospermia: Case Report and 
Literature Review. Urology 2016; 1(26):26-33. 
12.Hammami W, Kilani O, Khelifa MB, Ayed W, 
Abdelhak S, Bouzouita A, Zhioua F, Amouri A. 
Prevalence of Y chromosome microdeletions in 
infertile Tunisian men. In Annales de biologie 
clinique 2014; 1(3): 331-336. 
13.Choi DK, Gong IH, Hwang JH, Oh JJ, Hong 
JY. Detection of Y chromosome microdeletion is 
valuable in the treatment of patients with 
nonobstructive azoospermia and 
oligoasthenoteratozoospermia: sperm retrieval 
rate and birth rate. Korean journal of urology 
2013; 54(2):111-6. 
14.Ambulkar PS, Sigh R, Reddy MV, Varma PS, 
Gupta DO, Shende MR, Pal AK. Genetic risk of 
Azoospermia Factor (AZF) microdeletions in 
idiopathic cases of azoospermia and 
oligozoospermia in Central Indian population. 
Journal of clinical and diagnostic research: JCDR 
2014; 8(3):88. 
15.Iijima M, Koh E, Izumi K, Taya M, Maeda Y, 
Kyono K, Yoshida A, Namiki M. New molecular 
diagnostic kit to assess Y‐chromosome deletions 
in the Japanese population. International Journal 
of Urology 2014; 21(9):910-6. 
16.Mirfakhraie R, Mirzajani F, Kalantar SM, 
Montazeri M, Salsabili N, Pourmand GR, 
Houshmand M. High prevalence of AZFb 
microdeletion in Iranian patients with idiopathic 
non-obstructive azoospermia. Indian J Med Res 
2010; 132(1):265-70. 
17.Suganya J, Kujur SB, Selvaraj K, Suruli MS, 
Haripriya G, Samuel CR. Chromosomal 
abnormalities in infertile men from southern 
india. Journal of clinical and diagnostic research: 
JCDR 2015; 9(7):GC05. 
18.Mahjoubi F, Soleimani S, Mantegy S. 
Chromosomal Abnormalities in Infertile Men 
Referred to Iran Blood Transfusion Organization 
Research Center. Journal of Reproduction & 
Infertility 2010;11(3):175-8. 
 
